Rolling Out8h
A breakthrough in Parkinson’s disease detection
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
Q&A: How a scientist helped ban a chemical connected to Parkinson's disease
The U.S. will ban nearly all uses of the common industrial cleaning agent, trichloroethylene (TCE), this year—more than 50 ...
News Medical on MSN1h
Alzheimer’s and Parkinson’s linked to aging brain’s failing waste disposal
New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...
Parkinson's patients face increased depression, independence issues due to poor sleep
A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox ...
Northern Virginia Daily1d
Exercise class helps Parkinson's patients manage their symptoms
Patients living with Parkinson’s disease are encouraged to engage in regular exercise to help manage symptoms and improve ...
Kentucky Today5h
Lawmaker files bill to establish Ky. Parkinson’s Disease Research Registry
London, has collaborated with the London-based advocacy group Parkinson's In Motion and The Michael J. Fox Foundation (MJFF) ...
ScienceAlert on MSN11d
Parkinson's Discovery Suggests We Could Already Have an FDA-Approved Treatment
Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for ...
New York establishes statewide Parkinson's registry to advance research
New legislation signed into law by Governor Kathy Hochul is positioning New York as a leader in Parkinson’s Disease research. The new bill establ ...
Irish Independent on MSN12h
Maynooth University study reveals how poor sleep affects Parkinson’s patients
Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, ...
Inhibikase Therapeutics stops Parkinson's drug development as it fails to show benefits in study
Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...